CEO: Christian Itin

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.

Key numbers

Market Capitalization:564522343
Shares Outstanding: 44981860
Float: 44916052
Next Earning Date:2020-02-05
TTm EPS: -1.1187
TTm Dividend Rate:
200 days moving average:15.78
50 days moving average: 13.33
One day percent Change: -2.33

2016-09-30, 2017-09-30, 2018-09-30, 2018-12-31,
2016-09-30, 2017-09-30, 2018-09-30, 2018-12-31,